Literature DB >> 12933561

Analysis of left-censored longitudinal data with application to viral load in HIV infection.

H Jacqmin-Gadda1, R Thiébaut, G Chêne, D Commenges.   

Abstract

The classical model for the analysis of progression of markers in HIV-infected patients is the mixed effects linear model. However, longitudinal studies of viral load are complicated by left censoring of the measures due to a lower quantification limit. We propose a full likelihood approach to estimate parameters from the linear mixed effects model for left-censored Gaussian data. For each subject, the contribution to the likelihood is the product of the density for the vector of the completely observed outcome and of the conditional distribution function of the vector of the censored outcome, given the observed outcomes. Values of the distribution function were computed by numerical integration. The maximization is performed by a combination of the Simplex algorithm and the Marquardt algorithm. Subject-specific deviations and random effects are estimated by modified empirical Bayes replacing censored measures by their conditional expectations given the data. A simulation study showed that the proposed estimators are less biased than those obtained by imputing the quantification limit to censored data. Moreover, for models with complex covariance structures, they are less biased than Monte Carlo expectation maximization (MCEM) estimators developed by Hughes (1999) Mixed effects models with censored data with application to HIV RNA Levels. Biometrics 55, 625-629. The method was then applied to the data of the ALBI-ANRS 070 clinical trial for which HIV-1 RNA levels were measured with an ultrasensitive assay (quantification limit 50 copies/ml). Using the proposed method, estimates obtained with data artificially censored at 500 copies/ml were close to those obtained with the real data set.

Entities:  

Year:  2000        PMID: 12933561     DOI: 10.1093/biostatistics/1.4.355

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  29 in total

1.  Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors:  Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

2.  Dimension reduction in the linear model for right-censored data: predicting the change of HIV-I RNA levels using clinical and protease gene mutation data.

Authors:  Jie Huang; David Harrington
Journal:  Lifetime Data Anal       Date:  2004-12       Impact factor: 1.588

3.  Estimating the odds ratio when exposure has a limit of detection.

Authors:  Stephen R Cole; Haitao Chu; Lei Nie; Enrique F Schisterman
Journal:  Int J Epidemiol       Date:  2009-08-10       Impact factor: 7.196

4.  Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model.

Authors:  Thi Huyen Tram Nguyen; Emmanuelle Comets; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-11       Impact factor: 2.745

Review 5.  New approaches for censored longitudinal data in joint modelling of longitudinal and survival data, with application to HIV vaccine studies.

Authors:  Tingting Yu; Lang Wu; Peter Gilbert
Journal:  Lifetime Data Anal       Date:  2018-06-08       Impact factor: 1.588

6.  Likelihood-based methods for estimating the association between a health outcome and left- or interval-censored longitudinal exposure data.

Authors:  Kathleen A Wannemuehler; Robert H Lyles; Amita K Manatunga; Metrecia L Terrell; Michele Marcus
Journal:  Stat Med       Date:  2010-07-20       Impact factor: 2.373

7.  Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit.

Authors:  Ryan E Wiegand; Charles E Rose; John M Karon
Journal:  Stat Methods Med Res       Date:  2014-05-05       Impact factor: 3.021

8.  Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.

Authors:  Scott D Sagel; Brandie D Wagner; Margaret M Anthony; Peggy Emmett; Edith T Zemanick
Journal:  Am J Respir Crit Care Med       Date:  2012-08-16       Impact factor: 21.405

Review 9.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Analysis of cigarette purchase task instrument data with a left-censored mixed effects model.

Authors:  Wenjie Liao; Xianghua Luo; Chap T Le; Haitao Chu; Leonard H Epstein; Jihnhee Yu; Jasjit S Ahluwalia; Janet L Thomas
Journal:  Exp Clin Psychopharmacol       Date:  2013-01-28       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.